|
US3236730A
(en)
|
1962-01-04 |
1966-02-22 |
Miles Lab |
Blepharitis composition comprising antiseptic, quaternary ammonium compound, keratolytic agent and a chelating compound
|
|
US5602130A
(en)
|
1987-03-20 |
1997-02-11 |
Allergan |
Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
|
|
JP2891883B2
(ja)
*
|
1993-11-05 |
1999-05-17 |
学校法人近畿大学 |
抗白内障医薬組成物
|
|
WO1997020578A1
(en)
*
|
1995-12-04 |
1997-06-12 |
University Of Miami |
Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance
|
|
US5965606A
(en)
|
1995-12-29 |
1999-10-12 |
Allergan Sales, Inc. |
Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
|
|
EP0930072A1
(en)
|
1998-01-13 |
1999-07-21 |
Kartar Dr. Lalvani |
Vitamin and mineral containing compositions for the treatment of dry eye
|
|
US6348508B1
(en)
|
2000-04-04 |
2002-02-19 |
Bausch & Lomb Incorporated |
Method for treating dry eye
|
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
|
ATE355064T1
(de)
|
2001-10-26 |
2006-03-15 |
Angeletti P Ist Richerche Bio |
Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase
|
|
FR2833268B1
(fr)
|
2001-12-12 |
2005-07-08 |
Fabre Pierre Dermo Cosmetique |
Nouvelle association contenant un poloxamer et de l'acide chondroitine sulfurique et/ou une glycoproteine et son utilisation
|
|
KR100564386B1
(ko)
|
2002-05-13 |
2006-03-27 |
주식회사 마이코플러스 |
4-하이드록시-5-메톡시-4-[2-메틸-3-(3-메틸-2-부테닐)-2-옥시란닐]-1-옥사스피로[2,5]옥탄-6-온을 함유한 지루치료용 약제학적 조성물
|
|
US8420699B1
(en)
|
2002-06-19 |
2013-04-16 |
Irvine L. Dubow |
Composition and methods of treatment using deionized and ozonated solution
|
|
EP1531793A1
(en)
|
2002-07-23 |
2005-05-25 |
Novartis AG |
Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
|
|
EP2272340B1
(en)
|
2002-08-19 |
2018-03-14 |
Ira Sanders |
Botulinum toxin
|
|
US20040171561A1
(en)
|
2002-09-03 |
2004-09-02 |
Popp Karl F. |
Topical formulations for treatment of rosacea
|
|
EP1551399A4
(en)
|
2002-09-30 |
2011-01-05 |
Mark A Babizhayev |
METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
|
|
US20060188471A1
(en)
|
2002-10-31 |
2006-08-24 |
Podolsky Daniel K |
Methods of treating epithelial lesions
|
|
GB0225795D0
(en)
|
2002-11-05 |
2002-12-11 |
Guillon Michael |
Wipes
|
|
US20070269537A1
(en)
|
2003-02-10 |
2007-11-22 |
Bioderm Research |
Skin Condition Improvement Including Acne, Rosacea, and Topical Wounds by Artemisia Annua Extract via Iron Siderophore Trojan Horse Delivery System
|
|
GB0322448D0
(en)
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
|
US20050197614A1
(en)
|
2004-03-04 |
2005-09-08 |
Wilson Pritchard |
Occlusive biomedical devices, punctum plugs, and methods of use thereof
|
|
US8455016B2
(en)
|
2004-03-12 |
2013-06-04 |
Melbj Holdings, Llc |
Treatment for meibomian gland dysfunction or obstruction
|
|
US20050202097A1
(en)
|
2004-03-12 |
2005-09-15 |
Melbj Holdings, Llc, Florida |
Lubricant for the ocular surface
|
|
EP1621191A1
(en)
|
2004-07-29 |
2006-02-01 |
Werner Bollag |
Treatment of inflammatory diseases by RXR Antagonists
|
|
US20090214676A1
(en)
|
2005-04-30 |
2009-08-27 |
Tissuetech, Inc. |
Method for treating ocular demodex
|
|
CN101203236A
(zh)
*
|
2005-06-22 |
2008-06-18 |
坪田一男 |
角结膜疾病的预防或治疗剂
|
|
US7981095B2
(en)
|
2005-07-18 |
2011-07-19 |
Tearscience, Inc. |
Methods for treating meibomian gland dysfunction employing fluid jet
|
|
US8083787B2
(en)
|
2005-07-18 |
2011-12-27 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction
|
|
WO2013003594A2
(en)
|
2011-06-28 |
2013-01-03 |
Tearscience, Inc. |
Methods and systems for treating meibomian gland dysfunction using radio-frequency energy
|
|
WO2007070463A2
(en)
*
|
2005-12-12 |
2007-06-21 |
Riolan Technologies, Inc. |
Compositions, methods and kits for removing debris from an ocular area
|
|
CA2651815A1
(en)
|
2006-05-10 |
2007-11-22 |
Dxterity Diagnostics |
Detection of nucleic acid targets using chemically reactive oligonucleotide probes
|
|
WO2007137369A1
(en)
|
2006-05-31 |
2007-12-06 |
Medihoney Pty Ltd |
Medicinal compositions containing honey
|
|
WO2008027069A1
(en)
|
2006-08-21 |
2008-03-06 |
Tearscience, Inc. |
Method and apparatus for treating meibomian gland dysfunction employing fluid
|
|
US8249695B2
(en)
|
2006-09-29 |
2012-08-21 |
Tearscience, Inc. |
Meibomian gland imaging
|
|
US8090426B2
(en)
|
2006-10-27 |
2012-01-03 |
Felder Robin A |
Microelectronic biosensor plug
|
|
US20100204317A1
(en)
|
2006-11-03 |
2010-08-12 |
Qlt Inc. |
Methods of treating dermatological disorders or conditions
|
|
WO2008068866A1
(en)
*
|
2006-11-30 |
2008-06-12 |
Menicon Co., Ltd. |
Ophthalmic composition
|
|
BRPI0808410A2
(pt)
*
|
2007-02-28 |
2015-06-23 |
Aciex Therapeutics Inc |
Métodos e composições para normalizar secreções da glândula meibomiana
|
|
US8128968B2
(en)
|
2007-08-29 |
2012-03-06 |
Tissuetech, Inc. |
Compositions and methods for treating Demodex infestations
|
|
ES2667945T3
(es)
|
2007-10-08 |
2018-05-16 |
Aurinia Pharmaceuticals Inc. |
Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
|
|
WO2009120881A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Eric Donnenfeld |
Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics
|
|
CN104623741A
(zh)
|
2008-04-30 |
2015-05-20 |
马缇医疗股份有限公司 |
复合泪管植入物及相关方法
|
|
JP5661035B2
(ja)
|
2008-07-10 |
2015-01-28 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
眼および皮膚の疾患および症状の治療用のシクロスポリン誘導体
|
|
WO2010033800A2
(en)
|
2008-09-19 |
2010-03-25 |
Alacrity Biosciences, Inc. |
Tetracycline stabilizing formulations
|
|
CA2760591C
(en)
|
2009-05-01 |
2018-01-02 |
Advanced Vision Research, Inc. |
Cleanser compositions and methods for using the same
|
|
CN101612161A
(zh)
|
2009-08-07 |
2009-12-30 |
魏谠全 |
一种眼药组合物及其制剂
|
|
US9034830B2
(en)
*
|
2009-10-30 |
2015-05-19 |
Intratus, Inc. |
Methods and compositions for sustained delivery of drugs
|
|
US20110294897A1
(en)
|
2009-12-02 |
2011-12-01 |
Bridge Pharma, Inc. |
Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion
|
|
US20120093876A1
(en)
|
2010-10-13 |
2012-04-19 |
Aciex, Inc. |
Ophthalmic Formulations, Methods Of Manufacture And Methods of Normalizing Meibomian Gland Secretions
|
|
AU2011327785A1
(en)
|
2010-11-08 |
2013-03-07 |
Healor Ltd. |
Buffered ophthalmic compositions and methods of use thereof
|
|
WO2012092378A1
(en)
|
2010-12-29 |
2012-07-05 |
Inspire Pharmaceuticals, Inc. |
Method for treating blepharitis
|
|
WO2012092320A2
(en)
|
2010-12-29 |
2012-07-05 |
Nichamin Louis D |
Eye treatment
|
|
US20130281390A1
(en)
|
2010-12-29 |
2013-10-24 |
Kurt E. Brubaker |
Method for treating dry eye
|
|
KR101914940B1
(ko)
|
2011-01-26 |
2018-11-06 |
알러간, 인코포레이티드 |
안과 질환을 치료하기 위한 안드로겐 조성물
|
|
EP2711374A4
(en)
|
2011-05-20 |
2014-05-21 |
Univ Keio |
NEW METAL PROTEIN AND METHOD FOR THE PRODUCTION THEREOF, AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST HORN OR BINDING DAMAGE WITH THIS METAL PROTEIN
|
|
CA2840626A1
(en)
*
|
2011-06-29 |
2013-01-03 |
Insite Vision Incorporated |
Methods of treating recurrent meibomian glands disorder and thereby decreasing the frequency of recurrence
|
|
ITFI20120044A1
(it)
|
2012-03-01 |
2013-09-02 |
Biodue Spa |
Formulazione ad uso oftalmico comprendente olio di jojoba.
|
|
EP2838547B1
(en)
*
|
2012-04-16 |
2019-09-04 |
Lubrizol Advanced Materials, Inc. |
Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
|
|
US9238018B2
(en)
*
|
2012-11-20 |
2016-01-19 |
Revive Therapeutics Inc. |
Use of bucillamine in the treatment of gout
|
|
US9211397B2
(en)
*
|
2012-12-19 |
2015-12-15 |
Senju Usa, Inc. |
Patch for treatment of eyelid disease containing clobetasol
|
|
US9987235B2
(en)
*
|
2013-08-01 |
2018-06-05 |
Nicholas L. Abbott |
Methods and compositions for modifying mucous membranes
|
|
HUE14755117T2
(hu)
|
2013-08-14 |
2018-12-28 |
Kalvista Pharmaceuticals Ltd |
Plazma-kallikrein inhibitorok
|
|
EP3139903B1
(en)
|
2014-05-07 |
2019-07-03 |
Croma-Pharma Gesellschaft m.b.H. |
Aqueous ophthalmic solution and method for treating dry eye syndrome
|
|
US9668996B2
(en)
*
|
2014-06-04 |
2017-06-06 |
Tersus Life Sciences, LLC |
Methods of treating chronic dry eye disease using C16:1n7-palmitoleate and derivatives thereof
|
|
US9463201B2
(en)
*
|
2014-10-19 |
2016-10-11 |
M.G. Therapeutics Ltd |
Compositions and methods for the treatment of meibomian gland dysfunction
|
|
US10688122B2
(en)
|
2015-09-28 |
2020-06-23 |
Azura Ophthalmics Ltd. |
Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
|
|
US11040062B2
(en)
*
|
2016-04-14 |
2021-06-22 |
Azura Ophthalmics Ltd. |
Selenium disulfide compositions for use in treating meibomian gland dysfunction
|
|
JP2019513775A
(ja)
*
|
2016-04-19 |
2019-05-30 |
アズーラ オフサルミックス エルティーディー． |
角化症の処置のための組成物
|